Kane Biotech Inc (TSXV:KNE)

C$ 0.13 0 (0%) Market Cap: 17.23 Mil Enterprise Value: 18.60 Mil PE Ratio: 4.33 PB Ratio: 0 GF Score: 37/100

Q2 2024 Kane Biotech Inc Earnings Call Transcript
Aug 29, 2024

C$0.155 (+6.90%)

Earnings
Q4 2023 Kane Biotech Inc Earnings Call Transcript
Mar 26, 2024

C$0.105 (+5.00%)

Earnings
Q3 2023 Kane Biotech Inc Earnings Call Transcript
Nov 28, 2023

C$0.075 (+15.38%)

Earnings
Q2 2023 Kane Biotech Inc Earnings Call Transcript
Aug 29, 2023

C$0.08 (+6.67%)

Earnings
Q1 2023 Kane Biotech Inc Earnings Call Transcript
May 25, 2023

C$0.11

Earnings
Kane Biotech Inc Annual Shareholders Meeting Transcript
May 24, 2023
Q4 2022 Kane Biotech Inc Earnings Call Transcript
Apr 20, 2023

C$0.12

Earnings
Q3 2022 Kane Biotech Inc Earnings Call Transcript
Nov 24, 2022

C$0.085 (-5.56%)

Earnings
Q2 2022 Kane Biotech Inc Earnings Call Transcript
Aug 25, 2022

C$0.11 (-4.35%)

Earnings
Q1 2022 Kane Biotech Inc Earnings Call Transcript
May 26, 2022

C$0.09

Earnings
Kane Biotech Inc Annual Shareholders Meeting Transcript
May 25, 2022
Q4 2021 Kane Biotech Inc Earnings Call Transcript
Mar 24, 2022

C$0.125 (+13.64%)

Earnings
Q3 2021 Kane Biotech Inc Earnings Call Transcript
Nov 16, 2021

C$0.16

Earnings
Q4 2020 Kane Biotech Inc Earnings Call Transcript
Mar 25, 2021

C$0.16 (+10.34%)

Earnings

Q3 2022 Kane Biotech Inc Earnings Call Transcript

Nov 24, 2022 / 09:30PM GMT

Release Date Price: C$0.085 (-5.56%)

Transcript

Operator

Good day and thank you for standing by. Welcome to the Kane Biotech Q3 2022 financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I'd now like to hand the conference over to your first speaker today, to Nicole Sendey, Investor Relations. Please go ahead.

Nicole Sendey

Kane Biotech Inc. - Investor Relations

Thank you, operator. Good afternoon and welcome, everyone, to Kane Biotech's quarterly earnings conference call. We are delighted to have you join us today. This call will cover Kane's financial and operating results for the third quarter of 2022 along with a discussion of some of our recent highlights and goals for 2022 and beyond.

Following our prepared remarks, we'll open the conference call to a question-and-answer session. Our call today will be led by Kane's Chief Executive Officer, Marc Edwards.

Before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call do contain certain forward-looking

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.